International Clinical Trial: A Randomized Controlled Trial of Idebenone for Cognitive Impairment in Cerebral Small Vessel Disease

Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119095) titled 'A Randomized Controlled Trial of Idebenone for Cognitive Impairment in Cerebral Small Vessel Disease' on Feb. 14.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Cerebral small vessel disease

Intervention: Drug Group:Edaravone 30mg, three times daily, oral

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Drug Group:79;Control Group:79;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=308216

Disclaimer: Curated by HT Syndic...